COTA logo — Together, we can bring clarity to cancer care.

COTA

Together, we can bring clarity to cancer care.

Founded 2011 United States New York, United States 247 employees Series E Total: $109.00M AI, Biotechnology +2

General Information

Company Name COTA
Founded Year 2011
Location United States New York, United States
Founders / Decision Makers
Team member
Employees 247
Industries AI, Biotechnology, Health Care +1
Funding Stage Series E
Social

BounceWatch is an independent company data service, not affiliated with COTA. To contact COTA, visit cotahealthcare.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About COTA

COTA is an AI and biotechnology startup in the healthcare and life sciences industries, based in the United States. Established in 2011, the company's mission is to bring clarity to cancer care, as reflected in its slogan "Together, we can bring clarity to cancer care." COTA was founded by doctors, engineers, and data scientists with the aim of creating clarity from fragmented and often-inaccessible real-world data.

Using its proprietary technology, advanced analytics, and deep expertise, COTA organizes complex data to provide a comprehensive picture of cancer, advancing care and research with the data. The company's vision is to ensure that everyone affected by cancer has a clear path to care and to make this vision a reality.

The most recent investment in COTA was a Series E round, with Deerfield as the investor, which took place on 25 October 2022.

Taxonomy: oncology, real-world data, cancer care, precision medicine, healthcare data management, healthcare solutions, healthcare technology startups

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series E Undisclosed 1
Deerfield
25 Oct 2022
Series D $34.00M 5
Boston Millenia Partners, ONC Capital +3
18 Nov 2020
Debt Financing $10.00M 1
Varian
10 Nov 2020
Series C $40.00M 7
Boston Millenia Partners, IQVIA +5
21 Feb 2018
Series B $18.00M 1
Boston Millenia Partners
16 Dec 2016
Series B Undisclosed 7
Novartis, Celgene +5
24 May 2016
Series A $7.00M 3
Horizon Healthcare Services, Med-Metrix +1
23 Sep 2014

COTA Alternatives & Competitors

View All Alternatives
COTA vs

Pioneering AI-based cancer diagnostics in pathology

Series C
97 employees
AI, Analytics
COTA vs
Mendel.ai
Mendel.ai United States

Supercharge your clinical data workflows

Series B
167 employees
AI, Analytics
COTA vs

Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of de...

Seed
4 employees
AI, Health Care

FAQ About COTA

Together, we can bring clarity to cancer care.
COTA was founded in 2011.
COTA is headquartered in New York, United States.
COTA operates in AI, Biotechnology, Health Care and Life Sciences. Its work centres on oncology, real-world data, cancer care and precision medicine.
COTA has approximately 247 employees.
COTA has completed 7 funding rounds, raising a total of $109.00M. The latest funding stage is Series E.
Top alternatives and competitors to COTA include Ibex Medical Analytics, Mendel.ai, bridge7 Oncology, Cvergenx, The Royal Marsden NHS Foundation Trust. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
COTA and Ibex Medical Analytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for COTA, https://bouncewatch.com/company/cota, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes